Literature DB >> 1721270

Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.

A B Jain1, J J Fung, A G Tzakis, R Venkataramanan, K Abu-Elmagd, M Alessiani, J Reyes, W Irish, V Warty, S Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721270      PMCID： PMC2981795     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients.

Authors:  G Burckart; T Starzl; L Williams; A Sanghvi; C Gartner; R Venkataramanan; B Zitelli; J Malatack; A Urbach; W Diven; R Ptachcinski; B Shaw; S Iwatsuki
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

2.  Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

Authors:  A B Jain; R Venkataramanan; E Cadoff; J J Fung; S Todo; A Krajack; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

Authors:  R Venkataramanan; A Jain; V W Warty; K Abu-Elmagd; H Furakawa; O Imventarza; J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Effect of bile on cyclosporin absorption in liver transplant patients.

Authors:  M U Mehta; R Venkataramanan; G J Burckart; R J Ptachcinski; B Delamos; S Stachak; D H Van Thiel; S Iwatsuki; T E Starzl
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

5.  One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.

Authors:  S Todo; J J Fung; A Tzakis; A J Demetris; A Jain; M Alessiani; S Takaya; R Day; R Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066
  5 in total
  14 in total

1.  Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients.

Authors:  Violette Gijsen; Seema Mital; Ron H van Schaik; Offie P Soldin; Steven J Soldin; Ilse P van der Heiden; Irena Nulman; Gideon Koren; Saskia N de Wildt
Journal:  J Heart Lung Transplant       Date:  2011-09-17       Impact factor: 10.247

2.  FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.

Authors:  A Jain; R Venkataramanan; J Lever; V Warty; K Abu-Elmagd; H Furukawa; J Reyes; B Nour; A Asrian; A Tzakis
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

Review 3.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

5.  Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.

Authors:  W J Sam; M Aw; S H Quak; S M Lim; B G Charles; S Y Chan; P C Ho
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

Review 6.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

Authors:  P E Wallemacq; V Furlan; A Möller; A Schäfer; P Stadler; I Firdaous; A M Taburet; R Reding; S Clement De Clety; J De Ville De Goyet; E Sokal; L Lykavieris; V Van Leeuw; O Bernard; J B Otte; N A Undre
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

Review 9.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

10.  Ciclosporin kinetics in children after stem cell transplantation.

Authors:  A J Willemze; S C Cremers; R C Schoemaker; A C Lankester; J den Hartigh; J Burggraaf; J M Vossen
Journal:  Br J Clin Pharmacol       Date:  2008-04-30       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.